PCOS app targets insulin resistance in new approach

An app focused on insulin resistance in polycystic ovary syndrome (PCOS) is launching this week, aiming to offer personalised tools for women managing the condition.

Lilli Health says its Lilli App is the first comprehensive platform built specifically to address insulin resistance in PCOS – a hormone imbalance that affects up to 20 per cent of women aged 14 to 45. Symptoms can include irregular periods, weight gain, acne, unwanted hair growth and fertility problems.

PCOS is often associated with elevated insulin levels and insulin resistance, a condition where the body does not respond properly to insulin, the hormone that regulates blood sugar.

The app promotes what the company calls a “Low Insulin Lifestyle”, aimed at addressing these underlying metabolic challenges.

Lilli Health founder, Dr Ali Chappell, who has PCOS herself, said: “The Lilli App isn’t just another PCOS platform, it’s a new way forward for the millions of PCOS patients who have been given the wrong advice about nutrition leading to frustration, hopelessness and zero results.

“If you’re not targeting insulin, you’re not truly treating PCOS, and it’s why Lilli was created – to change that narrative, giving patients the knowledge, tools, and support to finally take control of their health.”

The Lilli App combines insulin tracking, personalised education and lifestyle tools.

Users can upload results from healthcare providers or use Lilli’s own metabolic testing kits.

The app then provides insights based on insulin levels and tracks changes over time.

Dr Steven J. Fleischman is from Sound Obstetrics and Gynecology and is associate chief of the department of obstetrics and gynaecology at Yale New Haven Hospital.

He said: “Addressing insulin resistance early, particularly in women of reproductive age, is critical to preventing obesity and its associated long-term health complications.

“Efforts to bridge this gap in care hold the potential to profoundly alter the course of women’s health for generations to come.”

Lilli Health says insulin testing is rarely used in clinical PCOS management, despite its relevance to both physical and reproductive symptoms.

The app aims to increase access to this testing and provide science-based tools to support daily management.